Shares of Health Care sector company Eli Lilly and moved 0.5% today, and are now trading at a price of $686.33. The Large-Cap stock's daily volume was 1,902,583 compared to its average volume of 4,275,416. The S&P 500 index returned a -0.0% performance.
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company is based in Indianapolis and has 47,000 full time employees. Its market capitalization is $615,260,880,896. Eli Lilly and currently offers its equity investors a dividend that yields 0.8% per year.
26 analysts are following Eli Lilly and and have set target prices ranging from $650.0 to $1190.0 per share. On average, they have given the company a rating of buy. At today's prices, LLY is trading -23.38% away from its average analyst target price of $895.77 per share.
Over the last year, LLY shares have gone down by -25.8%, which represents a difference of -42.2% when compared to the S&P 500. The stock's 52 week high is $972.53 per share and its 52 week low is $623.78. Although Eli Lilly and's average free cash flow over the last 5 years has been $4.21 Billion, they have been decreasing at an average rate of -3.3%. For this reason, investors may continue to shun the stock.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 8,817,900 | 5,057,800 | 3,760,100 | 374.46 |
| 2023 | 4,240,100 | 3,447,600 | 792,500 | -86.17 |
| 2022 | 7,585,700 | 1,854,300 | 5,731,400 | -5.36 |
| 2021 | 7,365,900 | 1,309,800 | 6,056,100 | 18.48 |
| 2020 | 6,499,600 | 1,387,900 | 5,111,700 | 34.42 |
| 2019 | 4,836,600 | 1,033,900 | 3,802,700 |
